Preclinical Imaging Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Preclinical Imaging Market by type of Product (Imaging Modalities, Single Photon emission computed tomography (SPECT), Micro Computed Tomography (Micro-CT), Magnetic Particle Imaging, Magnetic Resonance Imaging (MRI), Optical Imaging, X-Ray Imaging, Positron Emission Tomography (PET), Ultrasound , Reagents and Kits, Others), by Application (Research and Development, Drug Discovery), by End User (Biotech Companies, Pharmaceutical companies, Research institutes), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Preclinical Imaging Market size was valued at USD 870.4 million in 2021, growing at a CAGR of 7.1% during the forecast period 2022-2028. Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others. Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate global preclinical imaging market. According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012. Companies adopting product innovations to increase their market share. Currently, the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In-vivo imaging is increased usage in target identification, compound optimization and pre-Phase I study, and in the drug development process. Thus, it bridges the gap between in-vitro exploratory and in-vivo clinical research. Regions such as Latin America, Middle East, and Asia Pacific are witnessing an increase in foreign investments that is leading to greater revenue generation, for the market growth.

Key Developments:

In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio

In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector

In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia’s first 3D Optical imaging system at Novosibirsk


Preclinical Imaging Market

MARKET SUMMARY
-
7.1% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.1 %
  • Largest Market– North America
  • Fastest Growing Market– Europe

Preclinical Imaging Market

  • The report on global Preclinical Imaging Market gives historical, current, and future market sizes (US$ Mn) on the basis of type of product, application, end-use and region
  • Preclinical Imaging Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • MR Solutions (U.K.),
  • Siemens Ltd (U.S.),
  • Miltenyi Biotec (Germany),
  • Aspect Imaging (Canada),
  • MILabs B.V. (Netherlands),
  • Bruker Corporation (U.S.),
Drivers And Restraints

Preclinical Imaging Market

Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.


North-America got significant share

Preclinical Imaging Market

Geographically, global preclinical imaging market is segmented into Europe, North America, Latin America, Asia Pacific, and Middle East & Africa., North America expected to grow at significant rates due to increase in adoption of new technologies for better clinical outputs, technological advancements, and growing prevalence rates chronic diseases such as cardiovascular disease, cancer. According to the National Cancer Institute, in 2017, about 1,685,210 new cancer cases are expected to be diagnosed. Europe is expected to be another major market for preclinical imaging owing to factors such as increase in healthcare awareness among people and research and development activity for treating and preventing diseases. Asia-Pacific preclinical imaging market expected to show lucrative growth opportunity owing to cost-effective clinical and preclinical imaging services, coupled with favourable government policies.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Segmentation

Preclinical Imaging Market


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Preclinical Imaging Market Introduction
2.1. Global Preclinical Imaging Market – Taxonomy
2.2. Global Preclinical Imaging Market –Definitions
2.2.1. Product
2.2.2. Application
3. Global Preclinical Imaging Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Preclinical Imaging Market Dynamic Factors – Impact Analysis
3.6. Global Preclinical Imaging Market – Competition Landscape
4. Global Preclinical Imaging Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Preclinical Imaging Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Medical Devices
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. CT Imaging
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. MRI Imaging
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. PET/SPECT Imaging
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Multi-modal Imaging
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Optical Imaging
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Ultrasound Imaging
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Photoacoustic (PAT) Imaging
5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Reagents
5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
5.10. Services
5.10.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.10.3. Market Opportunity Analysis
6. Global Preclinical Imaging Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Hospitals
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Diagnostics Centers
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Preclinical Imaging Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application and Region, 2022-2028
8. North America Preclinical Imaging MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Medical Devices
8.1.2. CT Imaging
8.1.3. MRI Imaging
8.1.4. PET/SPECT Imaging
8.1.5. Multi-modal Imaging
8.1.6. Optical Imaging
8.1.7. Ultrasound Imaging
8.1.8. Photoacoustic (PAT) Imaging
8.1.9. Reagents
8.1.10. Services
8.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospitals
8.2.2. Diagnostics Centers
8.2.3. Others
8.3. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Preclinical Imaging Market – Opportunity Analysis Index, By  Product, Application, and Country, 2022-2028
8.5. North America Preclinical Imaging Market Dynamics – Trends
9. Europe Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Medical Devices
9.1.2. CT Imaging
9.1.3. MRI Imaging
9.1.4. PET/SPECT Imaging
9.1.5. Multi-modal Imaging
9.1.6. Optical Imaging
9.1.7. Ultrasound Imaging
9.1.8. Photoacoustic (PAT) Imaging
9.1.9. Reagents
9.1.10. Services
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospitals
9.2.2. Diagnostics Centers
9.2.3. Others
9.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Preclinical Imaging Market – Opportunity Analysis Index, By  Product, Application, and Country, 2022-2028
9.5. Europe Preclinical Imaging Market Dynamics – Trends
10. Asia-Pacific Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Medical Devices
10.1.2. CT Imaging
10.1.3. MRI Imaging
10.1.4. PET/SPECT Imaging
10.1.5. Multi-modal Imaging
10.1.6. Optical Imaging
10.1.7. Ultrasound Imaging
10.1.8. Photoacoustic (PAT) Imaging
10.1.9. Reagents
10.1.10. Services
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospitals
10.2.2. Diagnostics Centers
10.2.3. Others
10.3. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Preclinical Imaging Market – Opportunity Analysis Index, By  Product, Application, and Country, 2022-2028
10.5. Asia-Pacific Preclinical Imaging Market Dynamics – Trends
11. Latin America Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Medical Devices
11.1.2. CT Imaging
11.1.3. MRI Imaging
11.1.4. PET/SPECT Imaging
11.1.5. Multi-modal Imaging
11.1.6. Optical Imaging
11.1.7. Ultrasound Imaging
11.1.8. Photoacoustic (PAT) Imaging
11.1.9. Reagents
11.1.10. Services
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospitals
11.2.2. Diagnostics Centers
11.2.3. Others
11.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Preclinical Imaging Market – Opportunity Analysis Index, By  Product, Application, and Country, 2022-2028
11.5. Latin America Preclinical Imaging Market Dynamics – Trends
12. Middle East and Africa Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Medical Devices
12.1.2. CT Imaging
12.1.3. MRI Imaging
12.1.4. PET/SPECT Imaging
12.1.5. Multi-modal Imaging
12.1.6. Optical Imaging
12.1.7. Ultrasound Imaging
12.1.8. Photoacoustic (PAT) Imaging
12.1.9. Reagents
12.1.10. Services
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospitals
12.2.2. Diagnostics Centers
12.2.3. Others
12.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Preclinical Imaging Market – Opportunity Analysis Index, By  Product, Application, and Country, 2022-2028
12.5. MEA Preclinical Imaging Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Technology & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Bruker Corporation
13.2.2. Siemens A.G.
13.2.3. General Electric(GE)
13.2.4. Trifoil Imaging
13.2.5. PerkinElmer Inc.
13.2.6. Agilent Technologies
13.2.7. MILabs B.V
13.2.8. Fujifilm Holdings Corporation
13.2.9. MR Solutions Ltd
13.2.10. Li-Cor Biosciences
13.2.11. Mediso Ltd
13.2.12. Milabs BV
14. Research Methodology
15. Key Assumptions and Acronyms

Report

Company Profile

 

  • FUJIFILM Holdings Corporation (Japan),
  • MR Solutions (U.K.),
  • PerkinElmer Inc. (U.S.),
  • Siemens Ltd (U.S.),
  • Miltenyi Biotec (Germany),
  • Aspect Imaging (Canada),
  • MILabs B.V. (Netherlands),
  • Bruker Corporation (U.S.),
  • Mediso Ltd. (Hungary),
  • TriFoil Imaging (U.S.),
  • Carestream Health (U.S.)

Description

Preclinical Imaging Market size was valued at USD 870.4 million in 2021, growing at a CAGR of 7.1% during the forecast period 2022-2028. Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others. Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate global preclinical imaging market. According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012. Companies adopting product innovations to increase their market share. Currently, the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In-vivo imaging is increased usage in target identification, compound optimization and pre-Phase I study, and in the drug development process. Thus, it bridges the gap between in-vitro exploratory and in-vivo clinical research. Regions such as Latin America, Middle East, and Asia Pacific are witnessing an increase in foreign investments that is leading to greater revenue generation, for the market growth.

Key Developments:

In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio

In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector

In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia’s first 3D Optical imaging system at Novosibirsk

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX